BPC3 Consortium Members

Overview of Cohorts in the BPC3

The table below briefly summarizes information about the participating cohorts in the BPC3. These cohorts had accrued >500 cases of invasive breast and/or >500 cases of prostate cancer. All of the cohorts are supported by funding independent of the BPC3 Study.

Cohort Year Cohort Established Principal Investigator of BPC3/Institution
American Cancer Society (CPS-II) 1998 Mia Gaudet, Ph.D., and Victoria Stevens, Ph.D.
American Cancer Society
European Prospective Investigation Into Cancer and Nutrition (EPIC) 1992 Elio Riboli, M.D., M.P.H., M.Sc.
Imperial College, London
Physicians' Health Study (PHS) I* 1982 David J. Hunter, M.B.B.S., Sc.D.
Channing Laboratory,
Harvard School of Public Health
Nurses' Health Study (NHS) I* 1976
Nurses' Health Study (NHS) II* 1989
Health Professionals Follow-up Study (HPFS)* 1993
Women's Health Study (WHS) 1993 Julie Buring, Sc.D.
Harvard School of Public Health
Multiethnic Cohort (MEC) Study of Diet and Cancer 1993 Loic Le Marchand, M.D., Ph.D.
University of Hawaii-Manoa
Cancer Research Center of Hawaii
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)* 1993 Robert Hoover, M.D., Sc.D.
National Cancer Institute
Alpha-Tocopherol Beta-Carotene (ATBC) Study 1991 Demetrius Albanes, M.D.
National Cancer Institute

* In this instance, the principal investigator for the cohort differs from the principal investigator for the BPC3.

BPC3 Steering Committee

To achieve the goals of the consortium, a Steering Committee coordinates the efforts within and across the participating cohorts and scientific disciplines. The Steering Committee includes the four principal investigators for the cooperative agreements that fund participation of the cohorts in the BCP3 Study, the principal investigators of the cohorts themselves (which are funded independent of this study), and NCI Program staff as Ex Officio members. The Steering Committee coordinates the activities of the research components, decides on a timeline for specific subcomponents of the study (e.g., the order in which groups of genes are genotyped), coordinates pooling of data, and distributes parts of the pooled data analyses to BCP3 Study members.